NCT05880966

Brief Summary

Over 64 million people in the U.S. have a permanent disability, with mobility-related disability (MRD) representing the most prevalent disability type (13.7%). Adults with MRD are 66% more likely to be overweight or obese than their non-disabled peers. Exercise in adults with MRD is important for weight management and is associated with improvements in obesity-related health conditions including hypertension, hyperlipidemia, insulin processing/sensitivity, etc. However, over half (57%) of adults with MRD do not exercise, while 22% engage in exercise of insufficient duration or intensity to obtain health benefits. Adults with MRD face numerous barriers to participation in community-based exercise, and exercise is frequently limited to short-term referrals for outpatient physical and/or occupational therapy. High-intensity functional training (HIFT) represents a potentially effective strategy for community-based exercise to support body weight and obesity-related health conditions, in addition to improving physical function and aspects of psychosocial health for people with disabilities. Preliminary evidence supports the effectiveness of HIFT to improve body composition, cardiovascular and muscular fitness, insulin processing and insulin sensitivity in non-disabled adults who are overweight/obese. To date, no study has systematically evaluated the feasibility or effectiveness of a community-based HIFT intervention for improving obesity-related health outcomes in overweight/obese adults with MRD. Thus, the proposed study will implement a 6-mo. pilot trial to evaluate the feasibility and potential effectiveness of a HIFT intervention (60 min sessions/3 days/wk.) in 25 adults with MRD and overweight/obesity. This study will address the following aims: Aim 1: Evaluate the intervention feasibility based on participant recruitment, session attendance, retention, outcome assessment completion, and the results of semi-structured exit interviews to obtain information regarding experience and overall satisfaction with the intervention. Aim 2: Evaluate changes (baseline - 6 mos.) in weight and fat-mass/fat-free mass, and components of the metabolic syndrome (waist circumference, blood pressure, HDL-cholesterol, triglycerides, fasting glucose).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

April 17, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 30, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

March 10, 2025

Status Verified

June 1, 2024

Enrollment Period

2 years

First QC Date

April 17, 2023

Last Update Submit

March 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Weight

    Weight will be measured in duplicate using a portable calibrated, digital scale to the nearest 0.1 kg.

    Change from Baseline weight at 6 months (post-intervention)

Secondary Outcomes (23)

  • Body Composition

    Change from Baseline body comp at 6 months (post-intervention)

  • Waist Circumference

    Change from Baseline waist circumference at 6 months (post-intervention)

  • Blood Pressure

    Change from Baseline blood pressure (diastolic and systolic) at 6 months (post-intervention)

  • Glucose

    Change from Baseline fasting glucose at 6 months (post-intervention)

  • Cholesterol

    Change from Baseline HDL cholesterol at 6 months (post-intervention)

  • +18 more secondary outcomes

Other Outcomes (4)

  • Energy expenditure

    Week 12 of the intervention - one time exploratory measure

  • Attendance

    Observed each week of the 24-week intervention

  • Work Capacity

    Change in baseline work capacity (time; A1) at 12 weeks and 24 weeks of the intervention

  • +1 more other outcomes

Study Arms (1)

COBRE Single Group

EXPERIMENTAL

All participants will complete the 6-mos functional fitness interventions

Behavioral: Functional Fitness

Interventions

Six month, thrice weekly functional fitness sessions will include a warm-up (15 minutes), skill or strength work (30 minutes) and a cool down (15 minutes)

COBRE Single Group

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years of age
  • Have a permanent disability that affects mobility (1 year +);
  • Body mass index between 24-52
  • Never been a part of a functional fitness program before
  • Have no significant health impairment that would contraindicate exercise (physician clearance required)
  • Serve as their own guardian

You may not qualify if:

  • Younger than 18 years of age or 65 years or older
  • Have a disability that was acquired within 1 year of starting the study or has a non-permanent mobility limitation (e.g., broken arm);
  • Have a body mass index less than 24 or greater than 52
  • Has previously been involved in functional fitness
  • Unable to obtain physician clearance
  • Are not their own guardian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas

Lawrence, Kansas, 66045, United States

Location

MeSH Terms

Conditions

Mobility LimitationOverweightObesity

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody Weight

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2023

First Posted

May 30, 2023

Study Start

April 17, 2023

Primary Completion

March 30, 2025

Study Completion

April 30, 2025

Last Updated

March 10, 2025

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations